Cargando…
The Emerging Role of CD8(+) Tissue Resident Memory T (T(RM)) Cells in Antitumor Immunity: A Unique Functional Contribution of the CD103 Integrin
Cancer immunotherapy is aimed at stimulating tumor-specific cytotoxic T lymphocytes and their subsequent trafficking so that they may reach, and persist in, the tumor microenvironment, recognizing and eliminating malignant target cells. Thus, characterization of the phenotype and effector functions...
Autores principales: | Corgnac, Stéphanie, Boutet, Marie, Kfoury, Maria, Naltet, Charles, Mami-Chouaib, Fathia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104123/ https://www.ncbi.nlm.nih.gov/pubmed/30158938 http://dx.doi.org/10.3389/fimmu.2018.01904 |
Ejemplares similares
-
Cancer stem-like cells evade CD8(+)CD103(+) tumor-resident memory T (T(RM)) lymphocytes by initiating an epithelial-to-mesenchymal transition program in a human lung tumor model
por: Corgnac, Stéphanie, et al.
Publicado: (2022) -
Isolation of tumor-resident CD8(+) T cells from human lung tumors
por: Corgnac, Stéphanie, et al.
Publicado: (2021) -
Tumor-resident memory T cells as a biomarker of the response to cancer immunotherapy
por: Damei, Isabelle, et al.
Publicado: (2023) -
CD103(+)CD8(+) T(RM) Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17
por: Corgnac, Stéphanie, et al.
Publicado: (2020) -
Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
por: Durgeau, Aurélie, et al.
Publicado: (2018)